SCGB2A2 and breast cancer: Interestingly, when we evaluated the expression of SCGB2A2 (a classical marker of breast cancer), seven CTCs from P8 had high expression levels (Figure 6F), whereas other CSF‐CTCs had little to no expression, showing the advantage of scRNA‐seq over bulk RNA‐seq or IHC.